Displaying drugs 2026 - 2050 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Bedaquiline | 555.505 C32H31BrN2O2 |  | A diarylquinoline antimycobacterial used in combination with other antibacterials to treat pulmonary multidrug resistant tuberculosis (MDR-TB). | Diarylquinoline Antimycobacterial |
| Teniposide | 656.654 C32H32O13S |  | A cytotoxic drug used as an adjunct for chemotherapy induction in the treatment of refractory childhood acute lymphoblastic leukemia. | Podophyllotoxin Derivatives |
| Naldemedine | 570.646 C32H34N4O6 |  | An opioid antagonist used to to treat opioid-induced constipation. | Peripheral Opioid Receptor Antagonists |
| Adagrasib | 604.13 C32H35ClFN7O2 |  | A KRAS inhibitor indicated for the treatment of locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer in patients who have received at least one prior systemic therapy. | Antineoplastic Agents |
| Eluxadoline | 569.662 C32H35N5O5 |  | A mixed mu-opioid receptor agonist used to treat irritable bowel syndrome with diarrhea. | Antipropulsives / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome |
| Quinidine barbiturate | 556.652 C32H36N4O5 |  | The administration of quinidine derivatives helps to observe various skin and mucosal reactions. A papulopurpuric eruption in a patient (without thrombopenia) can be developed who is taking quinidine phenylethyl barbiturate... | Not Available |
| Deserpidine | 578.6527 C32H38N2O8 |  | An alkaloid that has been used to manage hypertension. | Secologanin Tryptamine Alkaloids |
| Mobocertinib | 585.709 C32H39N7O4 |  | An oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Tyrosine Kinase Inhibitors |
| Ebastine | 469.6576 C32H39NO2 |  | A second generation H1-receptor antagonist useful in the treatment of allergic rhinitis and urticaria. | Histamine H1 Antagonists |
| Fexofenadine | 501.6564 C32H39NO4 |  | A selective H1-antagonist for the symptomatic treatment of seasonal allergic rhinitis and chronic idiopathic urticaria. | Anti-Allergic Agents / Histamine H1 Antagonists / Histamine H1 Antagonists, Non-Sedating |
| Bromocriptine | 654.595 C32H40BrN5O5 |  | A dopamine D2 receptor agonist used for the treatment of galactorrhea due to hyperprolactinemia and other prolactin-related conditions, as well as in early Parkinsonian Syndrome. | Prolactine Inhibitors |
| Sparsentan | 592.76 C32H40N4O5S |  | An endothelin and angiotensin II receptor antagonist indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression. | Agents Acting on the Renin-Angiotensin System / Amides / Angiotensin 2 Receptor Blocker / Angiotensin II receptor antagonists / Angiotensin II Type 1 Receptor Blockers / Angiotensin Receptor Antagonists / BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Dual Endothelin Type A Receptor/Ang II Subtype 1 Receptor Antagonist (DEARA) / Endothelin Receptor Antagonists / OAT3/SLC22A8 Inhibitors / OATP1B3 inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates / Sulfones / Sulfur Compounds |
| Terfenadine | 471.6734 C32H41NO2 |  | An antihistamine for the treatment of allergy symptoms. | Benzhydryl Compounds / Histamine H1 Antagonists, Non-Sedating / Piperidines |
| Dihydro-alpha-ergocryptine | 577.726 C32H43N5O5 |  | A nootropic with an unknown mechanism of action indicated in individuals over sixty who manifest signs and symptoms of an idiopathic decline in mental capacity. | Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates |
| Epicriptine | 577.726 C32H43N5O5 |  | A nootropic with an unknown mechanism of action indicated in individuals over sixty who manifest signs and symptoms of an idiopathic decline in mental capacity. | Alkaloids / Dopamine Agonists |
| Ciclesonide | 540.697 C32H44O7 |  | A glucocorticoid used in the symptomatic relief of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents. | Glucocorticoids |
| Nelfinavir | 567.782 C32H45N3O4S |  | A viral protease inhibitor used in the treatment of HIV infection. | HIV Protease Inhibitors / Isoquinolines / Protease Inhibitors |
| Fulvestrant | 606.78 C32H47F5O3S |  | An estrogen receptor antagonist used to treat HR+ breast cancer that may also be HER2-. | Anti-Estrogens |
| Estradiol dienanthate | 496.732 C32H48O4 |  | An estrogen used in some combined hormonal oral contraceptives. | BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP1A2 Inhibitors (weak) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 CYP3A7 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Drugs that are Mainly Renally Excreted / Estradiol Congeners / Estranes / Estrenes / Fused-Ring Compounds / Gonadal Hormones / Gonadal Steroid Hormones / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / OATP1B1/SLCO1B1 Inhibitors / OCT1 inhibitors / OCT2 Inhibitors / Organic Anion Transporting Polypeptide 2B1 Inhibitors / P-glycoprotein substrates / Steroids / UGT1A1 Substrates |
| Steviolbioside | 642.739 C32H50O13 |  | Steviolbioside has been used in trials studying the treatment of HIV-1 Infection. | Stevia / Sweetening Agents |
| Demecarium | 556.7797 C32H52N4O4 |  | For the topical treatment of chronic open-angle glaucoma. | Cholinesterase Inhibitors / Parasympathomimetics |
| Rocuronium | 529.7742 C32H53N2O4 |  | A vecuronium analog used to facilitate tracheal intubation and to relax skeletal muscles during surgery. | Agents producing tachycardia |
| Thonzonium | 511.818 C32H55N4O |  | A cationic surfactant used to disperse exudate and cellular debris, as well as enhance the penetration of antimicrobials. | Amines / Ammonium Compounds / Nitrogen Compounds / Onium Compounds / Surface-Active Agents |
| Telmisartan | 514.6169 C33H30N4O2 |  | An ARB used to treat hypertension, diabetic nephropathy, and congestive heart failure. | Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics |
| Candesartan cilexetil | 610.671 C33H34N6O6 |  | An angiotensin receptor blocker used to treat hypertension, systolic hypertension, left ventricular hypertrophy, and delay progression of diabetic nephropathy. | Angiotensin II Antagonists and Diuretics |
Displaying drugs 2026 - 2050 of 2785 in total